These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 11806257

  • 1. [An extensive English study: reduced cardiovascular mortality and morbidity by statin].
    Nilsson P, Erhardt L.
    Lakartidningen; 2001 Dec 19; 98(51-52):5846-50. PubMed ID: 11806257
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV, Suntsov DS.
    Angiol Sosud Khir; 2009 Dec 19; 15(2):123-7. PubMed ID: 19806952
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M.
    MMW Fortschr Med; 2003 Feb 27; 145(9):35-6. PubMed ID: 12666527
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Statin plus niacin or ezetimibe? What combination for which patients?].
    Parhofer K.
    MMW Fortschr Med; 2009 Dec 03; 151(49-50):16. PubMed ID: 20085070
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
    Olsson AG.
    Lakartidningen; 2009 Dec 03; 103(1-2):22-3. PubMed ID: 16465841
    [No Abstract] [Full Text] [Related]

  • 10. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.
    Clin Ther; 2007 Feb 03; 29(2):253-60. PubMed ID: 17472818
    [Abstract] [Full Text] [Related]

  • 11. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr 26; 149(17):56-7. PubMed ID: 17674912
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
    Farmer JA.
    Curr Atheroscler Rep; 2009 Mar 26; 11(2):82-3. PubMed ID: 19228479
    [No Abstract] [Full Text] [Related]

  • 16. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U, Gathof BS.
    Eur J Med Res; 2004 Jan 26; 9(1):1-17. PubMed ID: 14766335
    [Abstract] [Full Text] [Related]

  • 17. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM, Attvall S, Båvenholm P.
    Lakartidningen; 2004 Nov 18; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract] [Full Text] [Related]

  • 18. [Few patients with coronary diseases are receiving lipid-lowering therapy].
    Stagmo M, Hofman-Bang C, Erhardt L, Rydén L.
    Lakartidningen; 2002 Apr 18; 99(16):1798-9, 1802-3. PubMed ID: 12043479
    [No Abstract] [Full Text] [Related]

  • 19. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH.
    Can J Cardiol; 2004 Aug 18; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [Abstract] [Full Text] [Related]

  • 20. [Statins and costs of prevented death cases].
    Robberstad T.
    Tidsskr Nor Laegeforen; 1997 Nov 20; 117(28):4131. PubMed ID: 9441454
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.